跳至主要内容
临床试验/IRCT20160422027520N11
IRCT20160422027520N11尚未招募2 期

Effects of Anti-CD20 monoclonal antibody on immunologic factors in elderly patients with ischemic stroke

Tabriz University of Medical Sciences0 个研究点目标入组 12 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
60 years 至 75 years(—)
性别
All

入选标准

  • Willingness to cooperate
  • Aged 60 to 75 years
  • Diagnosis of ischemic stroke by a neurologist
  • Radiological findings (MRI, CT) consistent with clinical diagnosis of ischemic stroke
  • NIHSS score between 6 and 22

排除标准

  • Use of nutritional supplements and antioxidant and alpha-lipoic acid during a month before the study
  • History of diabetes, high or low blood pressure and other chronic diseases (kidney, lung disorders, etc.), anemia, thrombocytopenia
  • A history of autoimmune diseases, immunodeficiency diseases, asthma and allergies
  • Viral infections (hepatitis B, influenza ...)
  • Occurrence of recurrence of disease during the study
  • Evidence from CT or MRI based on acute or chronic intracerebral hemorrhage,
  • arteriovenous malformation (AVM), Subarachnoid hemorrhage (SAH) brain aneurysm or tumor.
  • Symptoms or signs of neurology that quickly recover during screening and are likely to recover completely within 24 hours.
  • Not wanting to continue cooperation

研究者

相似试验